SteadyRx: Smartphone ART Adherence Intervention for Drug Users
Sponsor: Johns Hopkins University
This NA trial investigates HIV and Medication Adherence and is currently completed. Johns Hopkins University leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2018 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
-
Sep 2017 — May 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting · Phase: PHASE1 → NA
-
Jun 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE1
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins University
- National Institute on Drug Abuse (NIDA)
- Western Michigan University
For direct contact, visit the study record on ClinicalTrials.gov .